Stavenuiter AW et al. |
Protective Effects of Paricalcitol on Peritoneal Remodeling during Peritoneal Dialysis. |
2015 |
Biomed Res Int |
pmid:26605330
|
Riccio E et al. |
Effect of paricalcitol vs calcitriol on hemoglobin levels in chronic kidney disease patients: a randomized trial. |
2015 |
PLoS ONE |
pmid:25781618
|
Ritter CS et al. |
Differential expression and regulation of Klotho by paricalcitol in the kidney, parathyroid, and aorta of uremic rats. |
2015 |
Kidney Int. |
pmid:25692955
|
Thethi TK et al. |
Effect of paricalcitol on endothelial function and inflammation in type 2 diabetes and chronic kidney disease. |
2015 |
J. Diabetes Complicat. |
pmid:25633573
|
Bover J et al. |
Vitamin D, vitamin D receptor and the importance of its activation in patients with chronic kidney disease. |
2015 |
Nefrologia |
pmid:25611831
|
Kröpelin TF et al. |
Number and frequency of albuminuria measurements in clinical trials in diabetic nephropathy. |
2015 |
Clin J Am Soc Nephrol |
pmid:25568217
|
Trillini M et al. |
Paricalcitol for secondary hyperparathyroidism in renal transplantation. |
2015 |
J. Am. Soc. Nephrol. |
pmid:25194004
|
Cozzolino M et al. |
Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: results of the IMPACT-SHPT study. |
2014 |
Nephrol. Dial. Transplant. |
pmid:24500308
|
Wang AY et al. |
Effect of paricalcitol on left ventricular mass and function in CKD--the OPERA trial. |
2014 |
J. Am. Soc. Nephrol. |
pmid:24052631
|
Freundlich M et al. |
Paricalcitol downregulates myocardial renin-angiotensin and fibroblast growth factor expression and attenuates cardiac hypertrophy in uremic rats. |
2014 |
Am. J. Hypertens. |
pmid:24072555
|